2018
|
Invention
|
Cancer stem cell inhibitor. To provide a novel medicine for suppressing cancer stem cells. An inh... |
2017
|
Invention
|
Foam, screen foamer composition, and evaluation method for same. Provided is a product exhibiting... |
|
Invention
|
Foam, screen foamer composition, and evaluation method for same. Provided is a product that is ab... |
|
Invention
|
Pharmaceutical composition for treatment of infection. The present invention addresses the proble... |
|
Invention
|
Amorphizing agent, amorphous composition comprising amorphizing agent and utilization thereof. Th... |
2016
|
Invention
|
Naphthoquinone compound and nuclear factor kappa-b (nf-κb) inhibitor comprising same as active in... |
|
Invention
|
Pharmaceutical composition for external use.
A pharmaceutical composition for external use, incl... |
|
Invention
|
Anti-tritrichomonas agent.
An object of the present invention is to provide a novel anti-Tritric... |
|
Invention
|
Anti-tritrichomonas agent. An object of the present invention is to provide a novel anti-Tritrich... |
|
Invention
|
Antifungal pharmaceutical composition.
Disclosed is an antifungal agent for external use, which ... |
|
Invention
|
Luliconazole as anti-acanthamoeba agent and method for producing the same.
An anti-Acanthamoeba ... |
|
Invention
|
Luliconazole as anti-acanthamoeba agent and method for producing the same. An object is to provid... |
2015
|
Invention
|
External composition for screen foamers. The present invention addresses the issue of providing a... |
|
Invention
|
Antigiardial agent. The present invention aims to provide an agent for the treatment of giardiasi... |
|
Invention
|
Pharmaceutical composition including anti-fungal agent and steroid. The present invention address... |
|
Invention
|
Process for producing composition of emulsion preparation type.
preparing a composition, which f... |
|
Invention
|
Process for producing composition of emulsion preparation type. Provided is a technique for prepa... |
|
Invention
|
Method of evaluating pharmaceutical preparation containing luliconazole and index substance. Disc... |
2014
|
Invention
|
Pharmaceutical composition for treatment of pneumonia associated with fusarium fungus.
The prese... |
|
Invention
|
Pharmaceutical composition for treatment of pneumonia associated with fusarium fungus. The presen... |
|
Invention
|
Antifungal composition. Disclosed is a pharmaceutical composition for antifungal use, comprising:... |
|
Invention
|
External-use composition producing foamed state upon use. Compositions having an increased amount... |
|
Invention
|
External-use composition producing foamed state upon use. Provided is a means for heightening the... |
|
Invention
|
Pharmaceutical composition for treating vaginitis or pneumonia. Provided is a pharmaceutical comp... |
|
Invention
|
Resin container filled with antifungal pharmaceutical composition. Provided is a means for stably... |
|
Invention
|
Crystal having specific crystal habit and pharmaceutical composition containing the crystal as ac... |
2013
|
Invention
|
Pharmaceutical composition for diseases caused by pathogenic microorganisms such as aspergillus. ... |
|
Invention
|
Pharmaceutical composition for diseases caused by pathogenic microorganisms such as candida.
An ... |
|
Invention
|
Pharmaceutical composition for diseases caused by pathogenic microorganisms such as candida. An o... |
|
Invention
|
Crystal and pharmaceutical preparation containing the same crystal. An object is to provide means... |
|
Invention
|
Pharmaceutical composition containing luliconazole.
Means for controlling the formation amount o... |
|
Invention
|
Pharmaceutical composition containing luliconazole. Means for controlling the formation amount of... |
|
Invention
|
Crystalline form having specific crystal habit and pharmaceutical composition containing this cry... |
|
Invention
|
Use of surface free energy for differential evaluation of crystal, crystal evaluated on basis of ... |
|
Invention
|
Amide derivative and use of the same as stability index of a luliconazole pharmaceutical formulat... |
2012
|
Invention
|
Crystal having crystal habits and pharmaceutical composition obtained by processing the crystal. ... |
2011
|
Invention
|
Method of identifying abnormal cells by expression levels of etfb. Provided is a method for ident... |
|
Invention
|
Method of applying etfb to abnormal proliferation of cell, and abnormal proliferation inhibitor. ... |
|
Invention
|
Antimycotic pharmaceutical composition. 2 is halogen atom.)
|
2010
|
Invention
|
Antimycotic pharmaceutical composition. In a pharmaceutical composition for external use containi... |
2008
|
P/S
|
Drugs for medical purposes; pharmaceutical preparations. |